Maternal characteristics and migraine pharmacotherapy during pregnancy: Cross-sectional analysis of data from a large cohort study

Cephalalgia

Volumn 29, Issue 12, 2009, Pages 1267-1276

  Nezvalova Henriksen K ^a   Spigset, O ^b,c   Nordeng, H ^a,d  

^a UNIVERSITY OF OSLO   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Maternal characteristics; Migraine; Pharmacotherapy; Pregnancy

Indexed keywords

ALMOTRIPTAN; ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CODEINE; DICLOFENAC; ELETRIPTAN; ERGOTAMINE; IBUPROFEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PHENAZONE; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ADULT; ARTICLE; BACKACHE; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPENDENT VARIABLE; FEMALE; HUMAN; INDEPENDENT VARIABLE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MIGRAINE; NECK PAIN; PREGNANCY; SHOULDER PAIN;

ADULT; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MIGRAINE DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 74549140880     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01869.x     Document Type: Article

References (40)

1. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003 23 : 197 205.
2. Melhado EM, Maciel JA Jr., Guerreiro CAM. Headache during gestation: evaluation of 1101 women. Can J Neurol Sci 2007 34 : 187 192.
3. Ertresvåg JM, Zwart J-A, Helde G, Johnsen H-J, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005 111 : 233 237.
4. Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia 1997 17 : 765 769.
5. Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999 39 : 625 632.
6. Granella F, Sances G, Pucci E, Nappi RE, Chiotto N, Nappi G. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000 20 : 701 707.
7. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005 193 : 771 777.
8. Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Drug use during early pregnancy. Eur J Clin Pharmacol 2001 57 : 259 263.
9. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005 20 : 243 249.
10. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors. JAMA 1992 267 : 64 9.
11. Källén B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001 41 : 351 356.
12. Norwegian Institute of Public Health. The Norwegian mother and child cohort study. Oslo, Norway: Norwegian Institute of. Public Health 2008. [WWW document]. URL http://www.fhi.no/eway/?pid=238
13. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2008 WWW document]. URL http://www.whocc.no/atcddd/ (Accessed 3 April 2008).
14. Soldin PO, Dahlin J, O'Mara DM. Triptans in pregnancy. Ther Drug Monit 2008 30 : 5 9.
15. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005 45 : 3 31.
16. Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008 42 : 543 549.
17. Allais G, Castagnoli Gabellari I, Airola G, Schiapparelli P, Terzi MG, Mana O et al. Is migraine a risk factor in pregnancy? Neurol Sci 2007 28 : 184 187.
18. Rukmini M, Bushnell CD. Headache and pregnancy. Neurologist 2008 14 : 108 119.
19. Silberstein SD, Dodick D, Freitag F, Pearlman SH, Hahn SR, Scher AI et al. Pharmacological approaches to managing migraine and associated co-morbidities - clinical considerations for monotherapy versus polytherapy. Headache 2007 47 : 585 599.
20. Schwedt TJ. Serotonin and migraine: the latest developments. Cephalalgia 2007 27 : 1301 1307.
21. Magnus P, Irgens LM, Haug K, Nystad W, Skjærven R, Stoltenberg C. The MoBa Study Group. Cohort profile: the Norwegian mother and child cohort study (MoBa). Int J Epidemiol 2006 35 : 1146 1150. (Pubitemid 44605528)
22. Henry A, Crowther C. Patterns of drug use during and prior to pregnancy: the MAP study. Aust NZ J Obstet Gynaecol 2000 40 : 165 172.
23. Briggs G, Freeman RK, Yaffe SJ, eds. Ibuprofen. In : Drugs in pregnancy and lactation, 7th edn. Philadelphia, PA : Lippincott Williams & Wilkins 2005 : 800 803.
24. Schaefer C, Peters P, Miller RK, eds. Migraine medications. In : Drugs during pregnancy and lactation, 2nd edn. London : Elsevier 2007 : 42 3.
25. Schaefer C, Peters P, Miller RK, eds. ACE inhibitors. In : Drugs during pregnancy and lactation, 2nd edn. London : Elsevier 2007 : 203 207.
26. Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health 2005 5 : 12.
27. Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache 2007 47 : 1178 1183.
28. Marcus DA. The migraine-sleep link. Headache Pain 2006 17 : 75 8.
29. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia 2007 27 : 394 402.
30. Dodick DW, Eross EJ, Parish JM. Clinical, anatomical and physiologic relationship between sleep and headache. Headache 2003 43 : 282 292.
31. Toglia JU. Melatonin: a significant contributor to the pathogenesis of migraine. Med Hypotheses 2001 57 : 432 434.
32. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache 2006 46 : 1334 1343.
33. Jensen R, Stovner LJ. Epidemiology and co morbidity of headache. Lancet Neurol 2008 7 : 354 361.
34. Sclar DA, Robison LM, Skaer TL. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome. Headache 2008 48 : 126 129.
35. Wacogne C, Lacoste JP, Guillibert E, Hugues FC, Le Jeune C. Stress, anxiety, depression and migraine. Cephalalgia 2003 23 : 451 455.
36. Aamodt AH, Stovner LJ, Langhammer A, Hagen K, Zwart J-A. Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT study. Headache 2007 47 : 204 212.
37. Gudmundson LS, Thorgeirsson G, Sigfusson N, Sigvaldason H, Johannsson M. Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21 537 subjects. The Reykjavik Study. Cephalalgia 2005 26 : 436 444.
38. Bigal M, Lipton B. The prognosis of migraine. Curr Opin Neurol 2008 21 : 301 308.
39. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005 106 : 509 516 48.
40. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006 46 : 794 803.